ArticleCancer research and treatment2023

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.

Hongsik Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.